Fundraising Fox
Biochange
Founded 2017 · 17 employees on LinkedIn · 1 known investors
Find your way into Biochange
Sign up to find every way you can get introduced to Biochange
- Your email: who you already know at Biochange, and who your contacts know
- 2nd- and 3rd-degree connections: people you know who worked, studied or invested with the Biochange team
- Your LinkedIn: the connections who can make the intro for you
We rank every route by how warm it is, so you raise on warm intros instead of cold emails.
BioChange develops CellFoam, a biodegradable and biocompatible foam scaffold technology for regenerative medicine that supports tissue repair and organ recovery. Its product lines target dental, aesthetic, and human medical uses as well as veterinary care (including products like ReFoam, Revolette, ReGumVet, VetFoam, and vitaloc), with its veterinary line already in the U.S. market.
Founders & leadership
Investors · 1
Frequently asked questions
- What does Biochange do?
- BioChange develops CellFoam, a biodegradable and biocompatible foam scaffold technology for regenerative medicine that supports tissue repair and organ recovery. Its product lines target dental, aesthetic, and human medical uses as well as veterinary care (including products like ReFoam, Revolette, ReGumVet, VetFoam, and vitaloc), with its veterinary line already in the U.S. market.
- Who are Biochange's investors?
- Biochange's investors include quadraScope Venture Fund.